Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • rainbow over text: 'thank you NHS'
  • Register
  • Help
  • Contact us
  • Log out of your HL account

RedX Pharma plc (REDX) Ordinary Shares 1p

Sell:10.00p Buy:15.00p 0 Change: No change
Market closed Prices as at close on 5 June 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Takeover

RedX Pharma plc Ordinary Shares 1p

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 17 Apr 2020)

What is happening?

 

Redmile Group recently bought approximately 39.5% of the RedX Pharma plc shares in issue at a price of 15.5p per share. Under UK company law the company has to offer to buy all remaining RedX shares at the same price. The offer has been recommended by the board of RedX. As a holder of RedX Pharma plc Shares in your Hargreaves Lansdown Account you need to decide whether you wish to accept the Offer or not.

 

What are my choices?

 

Option 1 - You can accept the Offer. Under the terms of this Offer RedX Pharma plc Shareholders have been offered 15.5p in cash for each Share held.

 

Option 2 - The alternative is to do nothing. If you do not wish to participate in this Offer you are not required to take any action at this time.

 

When do I have to decide by?

 

Any acceptance must be received in this office by noon Tuesday 28 April 2020. If you return an acceptance by the deadline given, the resulting cash is expected to be credited to your Account by 15 May 2020.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:10.00p
Buy:15.00p
Change: No change
Market closed Prices as at close on 5 June 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Takeover

RedX Pharma plc Ordinary Shares 1p

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 17 Apr 2020)

What is happening?

 

Redmile Group recently bought approximately 39.5% of the RedX Pharma plc shares in issue at a price of 15.5p per share. Under UK company law the company has to offer to buy all remaining RedX shares at the same price. The offer has been recommended by the board of RedX. As a holder of RedX Pharma plc Shares in your Hargreaves Lansdown Account you need to decide whether you wish to accept the Offer or not.

 

What are my choices?

 

Option 1 - You can accept the Offer. Under the terms of this Offer RedX Pharma plc Shareholders have been offered 15.5p in cash for each Share held.

 

Option 2 - The alternative is to do nothing. If you do not wish to participate in this Offer you are not required to take any action at this time.

 

When do I have to decide by?

 

Any acceptance must be received in this office by noon Tuesday 28 April 2020. If you return an acceptance by the deadline given, the resulting cash is expected to be credited to your Account by 15 May 2020.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:10.00p
Buy:15.00p
Change: No change
Market closed Prices as at close on 5 June 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Takeover

RedX Pharma plc Ordinary Shares 1p

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 17 Apr 2020)

What is happening?

 

Redmile Group recently bought approximately 39.5% of the RedX Pharma plc shares in issue at a price of 15.5p per share. Under UK company law the company has to offer to buy all remaining RedX shares at the same price. The offer has been recommended by the board of RedX. As a holder of RedX Pharma plc Shares in your Hargreaves Lansdown Account you need to decide whether you wish to accept the Offer or not.

 

What are my choices?

 

Option 1 - You can accept the Offer. Under the terms of this Offer RedX Pharma plc Shareholders have been offered 15.5p in cash for each Share held.

 

Option 2 - The alternative is to do nothing. If you do not wish to participate in this Offer you are not required to take any action at this time.

 

When do I have to decide by?

 

Any acceptance must be received in this office by noon Tuesday 28 April 2020. If you return an acceptance by the deadline given, the resulting cash is expected to be credited to your Account by 15 May 2020.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
12.50p
Trade high:
n/a
Year high:
17.50p
Market capitalisation
Market cap.
:
£23.75 million
Previous close:
12.50p
Trade low:
n/a
Year low:
5.00p
P/E ratio:
n/a
Previous:
0.00p (0.00%)
Previous:
0.00p
Volume:
n/a
Dividend yield:
n/a
EMS:
7,500
Data delayed by at least 15 minutes.

Performance

Not available for this stock.

Fundamental data

Year ending: 30/09/2019 30/09/2018
Revenue (£m) 3.13 0.13
Profit before tax (£m) (6.33) (10.15)
Adjusted EPS (p): (3.40) (7.00)
P/E ratio n/a n/a
PEG n/a n/a
EPS growth (%) n/a n/a

Values are quoted in the stock's local currency: British pound

All fundamental data

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Ready to invest?

To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.

Compare accounts

Ready to take your first step?

To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.

Compare accounts

Important Documents

There are no documents available for this stock.

Broker forecasts

Due to changes in how we source investment data, Broker Forecasts are not currently available. We're sorry for any inconvenience this may cause.

Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.

Annual & interim reports

Annual & interim reports are not available for this stock.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. 'Broker forecast' and 'Recent trades' provided by MoneyAM. News and fundamental data provided by Digital Look.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.